Project Details
Description
A PHASE 1,0PEN-LABEL,DOSEESCALATING STUDYEVALUATING THE SAFETY, TOLERABILITY, PHARMACOKINETICS, PHARMACODYNAMICS AND CLINICAL ACTIVITY OF THE COMBINATION OF CLBROOI, AN ENGINEERED AUTOLOGOUS T-CELLPRODUCT,ANDSWI019,AN ANTIBODY-BASED BIOLOGIC, IN PATIENT
| Status | Active |
|---|---|
| Effective start/end date | 8/19/20 → 8/30/25 |
Funding
- SCRIPPS RESEARCH INSTITUTE DBA CALIBR
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.